These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
30. Vasopressor use in septic shock: an update. Leone M; Martin C Curr Opin Anaesthesiol; 2008 Apr; 21(2):141-7. PubMed ID: 18443479 [TBL] [Abstract][Full Text] [Related]
31. Hemodynamic effects of levosimendan added to dobutamine in patients with decompensated advanced heart failure refractory to dobutamine alone. Nanas JN; Papazoglou PP; Terrovitis JV; Kanakakis J; Dalianis A; Tsolakis E; Tsagalou EP; Agrios N; Christodoulou K; Anastasiou-Nana MI Am J Cardiol; 2004 Nov; 94(10):1329-32. PubMed ID: 15541261 [TBL] [Abstract][Full Text] [Related]
32. Successful reversal of resistent hypodynamic septic shock with levosimendan. Matejovic M; Krouzecky A; Radej J; Novak I Acta Anaesthesiol Scand; 2005 Jan; 49(1):127-8. PubMed ID: 15676005 [No Abstract] [Full Text] [Related]
33. Effect of intravenous positive inotropic therapy on myocardial damage in patients with dilated cardiomyopathy. Albayrak F; Demircan S; Yazici M; Arslandağ M Anadolu Kardiyol Derg; 2008 Feb; 8(1):69. PubMed ID: 18258539 [No Abstract] [Full Text] [Related]
34. Vasoactive drug support in septic shock. Dries DJ Shock; 2006 Nov; 26(5):529-30. PubMed ID: 17047528 [No Abstract] [Full Text] [Related]
35. Dobutamine to rescue the microcirculation? Spronk PE; Schultz MJ Crit Care Med; 2006 Oct; 34(10):2700; author reply 2700-1. PubMed ID: 16983282 [No Abstract] [Full Text] [Related]
36. Dobutamine stress echocardiography identifies anthracycline cardiotoxicity. Cottin Y; L'huillier I; Casasnovas O; Geoffroy C; Caillot D; Zeller M; Solary E; Guy H; Wolf JE Eur J Echocardiogr; 2000 Sep; 1(3):180-3. PubMed ID: 11916591 [TBL] [Abstract][Full Text] [Related]
37. Efficacy and safety of intermittent, long-term, concomitant dobutamine and levosimendan infusions in severe heart failure refractory to dobutamine alone. Nanas JN; Papazoglou P; Tsagalou EP; Ntalianis A; Tsolakis E; Terrovitis JV; Kanakakis J; Nanas SN; Alexopoulos GP; Anastasiou-Nana MI Am J Cardiol; 2005 Mar; 95(6):768-71. PubMed ID: 15757608 [TBL] [Abstract][Full Text] [Related]
38. Dobutamine compensates deleterious hemodynamic and metabolic effects of vasopressin in the splanchnic region in endotoxin shock. Martikainen TJ; Uusaro A; Tenhunen JJ; Ruokonen E Acta Anaesthesiol Scand; 2004 Sep; 48(8):935-43. PubMed ID: 15315609 [TBL] [Abstract][Full Text] [Related]
39. Relationship between dobutamine response of dyssynergic myocardium and angiographically documented blood supply. Klaar U; Berger R; Gwechenberger M; Wutte M; Porenta G; Sochor H; Maurer G; Baumgartner H J Am Soc Echocardiogr; 2003 Sep; 16(9):949-57. PubMed ID: 12931107 [TBL] [Abstract][Full Text] [Related]